09:37 AM EST - Sernova Corp. : Announced an update on its conformal coating immune protection technology program, that is used in combination with the Cell Pouch™. The goal of the program is to eliminate the need for chronic immunosuppression medications, currently used in islet cell transplantation for type 1 diabetes (T1D) treatment. Sernova Corp.
shares T.SVA are trading unchanged at $0.74.
